Bleeding disorders and reduced bone density
- PMID: 20505939
- DOI: 10.1007/s00296-010-1534-y
Bleeding disorders and reduced bone density
Abstract
In recent decays, quality of life and life expectancy of individuals with severe haemophilia A and B have been improved by better quality in treatment and more availability of blood coagulation products. Recently, new concerns have emerged in current groups such as auto-antibody inhibitors to coagulation factors and reduced bone density (RBD). RBD in bleeding disorders is becoming an escalating burden worldwide due to an increased in life expectancy and also in the ageing population with bleeding disorders. Here, we review published papers on bone mineral density of individuals with haemophilia A & B, a rare bleeding disorder entitled combined factor V and VIII deficiency and other rare bleeding disorders. It seems in individuals with bleeding disorders preventive measures including early detection, treatment and adequate physical activity, encouragement to be active in sports and finally anti-osteoporotic therapy must be done.
Similar articles
-
Are individuals with severe haemophilia A prone to reduced bone density?Rheumatol Int. 2008 Sep;28(11):1079-83. doi: 10.1007/s00296-008-0591-y. Epub 2008 May 24. Rheumatol Int. 2008. PMID: 18500466
-
Inherited bleeding disorders.Baillieres Clin Haematol. 1991 Apr;4(2):291-332. doi: 10.1016/s0950-3536(05)80162-3. Baillieres Clin Haematol. 1991. PMID: 1912663 Review.
-
Issues in the ageing individual with haemophilia and other inherited bleeding disorders: understanding and responding to the patients' perspective.Haemophilia. 2014 Jan;20(1):e1-6. doi: 10.1111/hae.12278. Epub 2013 Oct 14. Haemophilia. 2014. PMID: 24118548
-
Effect of low-dose factor VIII prophylaxis therapy on bone mineral density and 25(OH) vitamin D level in children with severe haemophilia A.Haemophilia. 2020 Mar;26(2):325-332. doi: 10.1111/hae.13917. Epub 2019 Dec 29. Haemophilia. 2020. PMID: 31884718
-
Management of rare coagulation disorders in 2018.Transfus Apher Sci. 2018 Dec;57(6):705-712. doi: 10.1016/j.transci.2018.10.009. Epub 2018 Oct 30. Transfus Apher Sci. 2018. PMID: 30392819 Review.
Cited by
-
Clinical and laboratory approaches to hemophilia a.Iran J Med Sci. 2015 May;40(3):194-205. Iran J Med Sci. 2015. PMID: 25999618 Free PMC article. Review.
-
Bone Density Status in Bleeding Disorders: Where Are We and What Needs to Be Done?J Bone Metab. 2017 Nov;24(4):201-206. doi: 10.11005/jbm.2017.24.4.201. Epub 2017 Nov 30. J Bone Metab. 2017. PMID: 29259958 Free PMC article. Review.
-
Clinical Care of Bone Health in Patients on the Immune Tolerance Induction's Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia.Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620913951. doi: 10.1177/1076029620913951. Clin Appl Thromb Hemost. 2020. PMID: 32598171 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical